Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:1248-1252

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gironacci, M. M.
Right arrow Articles by Peña, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gironacci, M. M.
Right arrow Articles by Peña, C.
Related Collections
Right arrow ACE/Angiotension receptors

(Hypertension. 2000;35:1248.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Angiotensin-(1-7) Reduces Norepinephrine Release Through a Nitric Oxide Mechanism in Rat Hypothalamus

Mariela M. Gironacci; Marcelo Vatta; Martín Rodriguez-Fermepín; Belisario E. Fernández; Clara Peña

From Instituto de Química y Fisicoquímica Biológicas (M.M.G., C.P.) and Cátedras de Fisiología (M.V.) y Fisiopatología (M.R.-F., B.E.F.), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.

Correspondence to Dr Clara Peña, Instituto de Química y Fisicoquímica Biológicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, 1113-Buenos Aires, Argentina. E-mail clara{at}qb.ffyb.uba.ar

Abstract—Angiotensin (Ang)-(1-7) elicits a facilitatory presynaptic effect on peripheral noradrenergic neurotransmission, and because biological responses to the heptapeptide on occasion are tissue specific, the present investigation was undertaken to study its action on noradrenergic neurotransmission at the central level. In rat hypothalamus labeled with [3H]-norepinephrine, 100 to 600 nmol/L Ang-(1-7) diminished norepinephrine released by 25 mmol/L KCl. This effect was blocked by the selective angiotensin type 2 receptor antagonist PD 123319 (1 µmol/L) and by the specific Ang-(1-7) receptor antagonist [D-Ala7]Ang-(1-7) (1 µmol/L) but not by losartan (10 nmol/L to 1 µmol/L), a selective angiotensin type 1 receptor antagonist. The inhibitory effect on noradrenergic neurotransmission caused by Ang-(1-7) was prevented by 10 µmol/L N{omega}-nitro-L-arginine methylester, an inhibitor of nitric oxide synthase activity, and was restored by 100 µmol/L L-arginine, precursor of nitric oxide synthesis. Methylene blue (10 µmol/L), an inhibitor of guanylate cyclase considered as the target of nitric oxide action, as well as Hoe 140 (10 µmol/L), a bradykinin B2-receptor antagonist, prevented the inhibitory effect of the heptapeptide on neuronal norepinephrine release, whereas no modification was observed in the presence of 0.1 to 10 µmol/L indomethacin, a cyclooxygenase inhibitor. Our results indicate that Ang-(1-7) has a tissue-specific neuromodulatory effect on noradrenergic neurotransmission, being inhibitory at the central nervous system by a nitric oxide–dependent mechanism that involves angiotensin type 2 receptors and local bradykinin production.


Key Words: angiotensin • norepinephrine • nitric oxide • angiotensin antagonist • bradykinin • prostaglandins




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. K. Becker, G. M. Etelvino, T. Walther, R. A. S. Santos, and M. J. Campagnole-Santos
Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1416 - H1424.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Paul, A. Poyan Mehr, and R. Kreutz
Physiology of local Renin-Angiotensin systems.
Physiol Rev, July 1, 2006; 86(3): 747 - 803.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Tsuda, I. Nishio, and M. M. Gironacci
Angiotensin-(1-7) and Bradykinin in Norepinephrine Release in the Central Nervous System of Hypertension
Hypertension, February 1, 2005; 45(2): e8 - e8.
[Full Text] [PDF]


Home page
HypertensionHome page
M. M. Gironacci, M. S. Valera, I. Yujnovsky, and C. Pena
Angiotensin-(1-7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats
Hypertension, November 1, 2004; 44(5): 783 - 787.
[Abstract] [Full Text] [PDF]